Se Jin Im

6.1k total citations · 4 hit papers
49 papers, 3.3k citations indexed

About

Se Jin Im is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Se Jin Im has authored 49 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 12 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Se Jin Im's work include Immune Cell Function and Interaction (21 papers), Immunotherapy and Immune Responses (16 papers) and T-cell and B-cell Immunology (12 papers). Se Jin Im is often cited by papers focused on Immune Cell Function and Interaction (21 papers), Immunotherapy and Immune Responses (16 papers) and T-cell and B-cell Immunology (12 papers). Se Jin Im collaborates with scholars based in South Korea, United States and Brazil. Se Jin Im's co-authors include Rafi Ahmed, Masao Hashimoto, Haydn Kissick, Gordon J. Freeman, Tahseen H. Nasti, Junghwa Lee, Helder I. Nakaya, J. Scott Hale, Ronald N. Germain and Michael Y. Gerner and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Se Jin Im

49 papers receiving 3.3k citations

Hit Papers

Defining CD8+ T cells that provide the proliferative burs... 2016 2026 2019 2022 2016 2018 2019 2021 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Se Jin Im South Korea 21 2.4k 1.9k 507 325 144 49 3.3k
J. Scott Hale United States 21 2.4k 1.0× 1.2k 0.6× 675 1.3× 281 0.9× 107 0.7× 45 3.4k
Henry Chiu United States 14 1.4k 0.6× 1.3k 0.7× 393 0.8× 296 0.9× 179 1.2× 23 2.3k
Andreas Wieland United States 25 2.4k 1.0× 2.1k 1.1× 671 1.3× 367 1.1× 288 2.0× 48 3.6k
Alessandra Zingoni Italy 39 3.5k 1.4× 1.5k 0.8× 1.1k 2.3× 357 1.1× 121 0.8× 77 4.8k
Valérie Dutoit Switzerland 35 2.2k 0.9× 1.2k 0.7× 1.2k 2.4× 262 0.8× 209 1.5× 83 3.3k
Tao Dao United States 28 1.8k 0.7× 1.3k 0.7× 1.2k 2.4× 233 0.7× 167 1.2× 77 3.1k
Ian F. Hermans New Zealand 36 3.1k 1.3× 1.1k 0.6× 934 1.8× 271 0.8× 110 0.8× 107 4.2k
Jason R. Baird United States 23 1.3k 0.5× 941 0.5× 492 1.0× 166 0.5× 164 1.1× 40 2.0k
Yajun Guo China 34 1.2k 0.5× 1.1k 0.6× 1.2k 2.3× 229 0.7× 157 1.1× 95 3.1k
Pascale André France 29 4.8k 2.0× 2.6k 1.4× 492 1.0× 196 0.6× 127 0.9× 78 5.5k

Countries citing papers authored by Se Jin Im

Since Specialization
Citations

This map shows the geographic impact of Se Jin Im's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Se Jin Im with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Se Jin Im more than expected).

Fields of papers citing papers by Se Jin Im

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Se Jin Im. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Se Jin Im. The network helps show where Se Jin Im may publish in the future.

Co-authorship network of co-authors of Se Jin Im

This figure shows the co-authorship network connecting the top 25 collaborators of Se Jin Im. A scholar is included among the top collaborators of Se Jin Im based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Se Jin Im. Se Jin Im is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Im, Se Jin, Kyungmin Lee, & Sang‐Jun Ha. (2024). Harnessing IL-2 for immunotherapy against cancer and chronic infection: a historical perspective and emerging trends. Experimental & Molecular Medicine. 56(9). 1900–1908. 6 indexed citations
2.
Lee, Su Jin, et al.. (2024). Two distinct subpopulations of marginal zone B cells exhibit differential antibody-producing capacities and radioresistance. Cellular and Molecular Immunology. 21(4). 393–408. 1 indexed citations
3.
Lee, Kyungmin, et al.. (2023). Defining a TCF1-expressing progenitor allogeneic CD8+ T cell subset in acute graft-versus-host disease. Nature Communications. 14(1). 5869–5869. 4 indexed citations
4.
Jin, Eun‐Ju, Shibo Wei, Yosep Ji, et al.. (2023). The impact of cancer cachexia on gut microbiota composition and short-chain fatty acid metabolism in a murine model. BMB Reports. 56(7). 404–409. 9 indexed citations
5.
Park, Eun‐Ji, Hyun Soo Kim, Se Jin Im, et al.. (2023). Ssu72 phosphatase is essential for thermogenic adaptation by regulating cytosolic translation. Nature Communications. 14(1). 1097–1097. 6 indexed citations
6.
Jin, Eun‐Ju, Shibo Wei, Yunju Jo, et al.. (2023). Oral administration of ginseng berry concentrate improves lactate metabolism and increases endurance performance in mice. BMB Reports. 56(6). 353–358. 2 indexed citations
7.
Lee, Junghwa, et al.. (2023). IL-15 promotes self-renewal of progenitor exhausted CD8 T cells during persistent antigenic stimulation. Frontiers in Immunology. 14. 1117092–1117092. 27 indexed citations
8.
Im, Se Jin, et al.. (2023). Expression and function of CD51 on CD8 T cells as an immunomodulatory target. Biochemical and Biophysical Research Communications. 661. 56–63. 2 indexed citations
9.
Kim, Jeehong, et al.. (2022). Comparison of Virulence between Two Main Clones (ST11 and ST307) of Klebsiella pneumoniae Isolates from South Korea. Microorganisms. 10(9). 1827–1827. 5 indexed citations
10.
Eberhardt, Christiane S., Haydn Kissick, Mihir R. Patel, et al.. (2021). Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer. Nature. 597(7875). 279–284. 197 indexed citations breakdown →
11.
Chang, Daniel Y., Andreas Wieland, Zheng-Rong Tiger Li, et al.. (2020). T Cell Receptor Diversity and Lineage Relationship between Virus-Specific CD8 T Cell Subsets during Chronic Lymphocytic Choriomeningitis Virus Infection. Journal of Virology. 94(20). 12 indexed citations
12.
Buchwald, Zachary S., Tahseen H. Nasti, Christiane S. Eberhardt, et al.. (2020). Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy. Journal for ImmunoTherapy of Cancer. 8(2). e000867–e000867. 104 indexed citations
13.
Jadhav, Rohit R., Se Jin Im, Bin Hu, et al.. (2019). Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade. Proceedings of the National Academy of Sciences. 116(28). 14113–14118. 154 indexed citations
14.
Hudson, William Henry, Masao Hashimoto, Andreas Wieland, et al.. (2019). Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection. Immunity. 51(6). 1043–1058.e4. 377 indexed citations breakdown →
15.
Im, Se Jin, et al.. (2018). Recent Trends in Photodynamic Therapy Using Upconversion Nanoparticles. Applied Chemistry for Engineering. 29(2). 138–146. 1 indexed citations
16.
Im, Se Jin, Masao Hashimoto, Michael Y. Gerner, et al.. (2016). Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature. 537(7620). 417–421. 1315 indexed citations breakdown →
17.
Namkoong, Hong, Yong Bok Seo, Donghoon Choi, et al.. (2013). Enhancement of antigen-specific CD8 T cell responses by co-delivery of Fc-fused CXCL11. Vaccine. 32(10). 1205–1212. 20 indexed citations
18.
Im, Se Jin, Se Hwan Yang, Dong Hoon Choi, et al.. (2011). Natural Form of Noncytolytic Flexible Human Fc as a Long-Acting Carrier of Agonistic Ligand, Erythropoietin. PLoS ONE. 6(9). e24574–e24574. 23 indexed citations
20.
Kim, Chae Young, et al.. (2007). In vivo kinetics and biodistribution of HB-110, a novel HBV DNA vaccine, after administration in Mice. Archives of Pharmacal Research. 30(3). 355–360. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026